Spinal Muscular Atrophy Awareness Month 2026 (August): How to Support
August is Spinal Muscular Atrophy Awareness Month. Together, we can increase awareness of SMA and support patients living in it. Spinal Muscular Atrophy is a genetic condition that affects the motor neurons. It results in weakness of muscles. During SMA awareness month, organizations, communities and individuals come together to support education, treatments and care for SMA.

- What Is Spinal Muscular Atrophy? A Simple Explanation for Parents 💚
- Types of SMA — A Complete Simple Breakdown 💚
- SMA Statistics 2025–2026: The Numbers Every Parent Should Know 📊
- ⚠️ Warning Signs of SMA in Children — A Parent’s Checklist
- 🔴 Signs in Babies (0–6 Months) — Possible SMA Type 1
- 🟡 Signs in Older Babies and Toddlers (6–18 Months) — Possible SMA Type 2
- 🟠 Signs in Children (18 Months and Older) — Possible SMA Type 3
- 💡 For Non-Verbal Children with Special Needs
- 🧬 Newborn Screening for SMA — What Every Parent Must Know
- 💊 FDA-Approved SMA Treatments in 2025–2026 — A Side-by-Side Comparison
- 🌟 SMA and Children with Other Special Needs
- 🏠 Daily Life with SMA — Practical Tips for Families
- 🏫 SMA at School — IEP, 504, and Advocacy Checklist for Parents
- 💛 Emotional Support for SMA Families — You Are Not Navigating This Alone
- Importance of SMA Awareness Month
- Support Research Efforts
- Inspire Hope
- Increases Public Awareness
- Supports SMA Community
- Promotes Early Diagnosis of SMA
- How to Participate in Spinal Muscular Atrophy Awareness Month?
- Connect with the SMA Community
- Show Your Support for Spinal Muscular Atrophy
- Educate Yourself About SMA
- Support Policies and Research Funds
- Voice Search
- ❓ FAQs — Spinal Muscular Atrophy Awareness Month
- Q: What month is Spinal Muscular Atrophy Awareness Month?
- Q: What is the most common type of SMA in children?
- Q: Can a child with SMA go to school?
- Q: Is SMA hereditary?
- Q: What is the newest SMA treatment approved by the FDA?
- Q: How early can SMA be detected?
- Q: What is the green ribbon for SMA Awareness Month?
- Conclusion
What Is Spinal Muscular Atrophy? A Simple Explanation for Parents 💚
Spinal Muscular Atrophy — or SMA — is one of those medical terms that sounds complicated. But the core idea is actually straightforward. And understanding it clearly can make a real difference for your family.
SMA is a genetic condition. It affects the motor neurons — the nerve cells in the spinal cord that carry messages from the brain to the muscles. In a child with SMA, these motor neurons are damaged or lost. As a result, the muscles do not receive the signals they need to move properly. Over time, the muscles become weaker.
This weakness can affect a child’s ability to:
- Sit up or hold their head upright
- Crawl or walk
- Swallow food and liquids safely
- Breathe without assistance
Here is something important that parents often do not know right away: SMA does not affect intelligence or cognitive ability. A child with SMA thinks, learns, feels, and communicates just like any other child. Their mind is fully intact. Only their muscle function is affected. (Source: Cure SMA)
SMA is caused by a missing or faulty gene called SMN1 (Survival Motor Neuron 1). This gene normally tells the body to produce a protein that keeps motor neurons alive. Babies usually receive two copies of this gene — one from the mother and one from the father. A baby born with SMA has received a missing or faulty SMN1 gene copy from both parents.
That is why SMA can appear even when both parents are completely healthy carriers. In fact, it is estimated that 1 in 50 Americans is a gene carrier — most of whom have no idea. (Source: State of Michigan SMA Proclamation)
Types of SMA — A Complete Simple Breakdown 💚
Not all SMA is the same. There are several different types, and the type your child has matters enormously — both for understanding what to expect and for treatment decisions.
The types are classified mainly by when symptoms begin and how severe the muscle weakness becomes. Generally speaking, the earlier symptoms start, the more severe the condition.
| SMA Type | Also Called | When Symptoms Begin | Key Characteristics | Mobility Outlook (Without Treatment) |
|---|---|---|---|---|
| Type 0 | Prenatal SMA | Before birth | Reduced fetal movement; very severe at birth | Extremely limited; rarest form |
| Type 1 | Werdnig-Hoffmann Disease | Within first 6 months | Cannot sit without support; breathing difficulties | Without treatment, most children will not survive beyond 2 years of age without permanent ventilatory support |
| Type 2 | Dubowitz Disease | 6–18 months | Can sit but cannot stand or walk independently | Wheelchair dependent; children can survive to early adulthood but will never walk |
| Type 3 | Kugelberg-Welander Disease | After 18 months | Can walk, but may lose ability over time | Can walk; may need wheelchair assistance in later years |
| Type 4 | Adult-onset SMA | After age 21 | Mild muscle weakness beginning in adulthood | Mostly ambulatory throughout life |
The most important thing to understand is this: with the breakthrough treatments now available, the natural progression outlined above is no longer inevitable for many children — especially those diagnosed early. The trajectory of SMA has been fundamentally changed by modern medicine. (Source: SMA News Today)
Which Type Is Most Common?
SMA Type 1 is the most common and most severe form. It accounts for approximately 60% of all SMA diagnoses. SMA Type 2 is the next most common. Together, Types 1 and 2 represent the vast majority of childhood SMA diagnoses that families navigate.
SMA Statistics 2025–2026: The Numbers Every Parent Should Know 📊
These statistics help paint the true picture of how SMA affects families — and why SMA Awareness Month matters so deeply.
| Statistic | Data | Source |
|---|---|---|
| How many babies are born with SMA | Approximately 1 in 15,000 births in the United States | Cure SMA via CGTlive |
| Carrier rate in the US population | 1 in 50 Americans is a gene carrier | State of Michigan Proclamation, 2025 |
| SMA is the leading genetic cause of infant death | SMA is the leading genetic cause of death in babies under the age of two | National Day Calendar |
| SMA prevalence in the US | Approximately 4 in every 100,000 people in the US have SMA | Days of the Year |
| SMA cases due to SMN1 gene deletion | Approximately 95% of SMA patients present with homozygous deletion of the SMN1 gene | NIH / PMC |
| Children who met motor milestones with presymptomatic treatment | Patients with 3–4 copies of SMN2 treated presymptomatically follow normal developmental timelines | NIH / PMC |
| Zolgensma trial — alive at 14 months | 91% of individuals with SMA Type 1 treated with Zolgensma were alive at 14 months | MedRAC @ UNC |
| Evrysdi — sitting independently at 23+ months | After 23 or more months of treatment, 81% of patients were alive without permanent ventilation | Managed Healthcare Executive |
| SMA Awareness Month founding year | Founded in 1996 by Cure SMA — led since by the patient community | Days of the Year |
Looking at these numbers together tells a powerful story. SMA is rare — but its impact is devastating without intervention. And with early diagnosis, the outcomes today are genuinely remarkable compared to even ten years ago.
⚠️ Warning Signs of SMA in Children — A Parent’s Checklist
One of the most critical challenges with SMA is that symptoms can look like ordinary developmental variation at first. A baby who seems a bit “floppy” or a toddler who is “slower to walk” may simply be dismissed as developing at their own pace.
For parents of special needs children, who are already navigating complex developmental profiles, this makes SMA symptoms even easier to miss.
Use this checklist. Share it with your pediatrician.
🔴 Signs in Babies (0–6 Months) — Possible SMA Type 1
- ✅ Baby feels unusually limp or floppy when held (“frog leg” posture at rest)
- ✅ Baby has weak cry or weak suck during feeding
- ✅ Baby does not hold their head up at expected age
- ✅ Breathing appears labored — chest moves more than belly during breathing
- ✅ Baby startles easily but has limited arm and leg movement in response
- ✅ Difficulty swallowing or frequent choking during feeding
- ✅ Tongue fasciculations — a subtle rippling movement of the tongue (a key clinical sign)
🟡 Signs in Older Babies and Toddlers (6–18 Months) — Possible SMA Type 2
- ✅ Can sit when placed but cannot get into a sitting position alone
- ✅ Never pulls to stand or attempts to stand at expected developmental stage
- ✅ Hand tremors — small shaking movements of the hands
- ✅ Falls frequently or tires very quickly during physical activity
- ✅ Spine begins to curve — scoliosis developing in early childhood
- ✅ Difficulty with stairs or uneven ground
🟠 Signs in Children (18 Months and Older) — Possible SMA Type 3
- ✅ Gradually losing the ability to run, climb, or walk distances that were previously manageable
- ✅ Frequent falls — especially tripping over flat ground with no obvious cause
- ✅ Difficulty raising arms above shoulders (brushing hair, reaching high shelves)
- ✅ Walking on tiptoe or developing an unusual gait pattern
- ✅ Progressive fatigue that worsens compared to peers
💡 For Non-Verbal Children with Special Needs
If your child has autism, intellectual disability, or another condition that affects their communication, they may not be able to tell you about muscle weakness or fatigue. Instead, watch for:
- Sudden changes in posture — slumping where they previously sat upright
- Refusing physical activities they used to enjoy
- Increased reliance on support when sitting or standing
- Changes in breathing patterns, especially during sleep
- A drop in stamina that seems unusual even for them
If you notice any of these signs — even if your child already has another diagnosis — mention them to your pediatrician and ask specifically about motor neuron evaluation. (Source: HRSA Newborn Screening)
🧬 Newborn Screening for SMA — What Every Parent Must Know
Newborn screening for SMA can be life-saving. The reason is simple: infants and children with SMA who are identified and treated at an early stage, especially those treated pre-symptomatically, show much better motor development than those diagnosed only after symptoms appear. By the time symptoms are visible, a significant number of motor neurons have already been permanently lost.
Is Newborn Screening for SMA Mandatory?
In the United States, SMA was added to the Recommended Uniform Screening Panel (RUSP) in 2018. As of 2018, the RUSP recommends that state newborn screening programs include SMA. However, individual states implement screening programs on their own timelines — meaning coverage is not yet universal across all states. (Source: HRSA)
Action step for parents: Ask your hospital or pediatrician directly — “Was my newborn screened for SMA?” Do not assume it happened automatically.
What Happens If the Screen Is Positive?
A positive newborn screen for SMA does not automatically mean your child will develop severe symptoms. The outcome depends heavily on how many copies of the SMN2 gene your child carries. Patients with 3–4 copies of SMN2 identified through newborn screening follow normal developmental timelines when treated early. Those with 2 copies require urgent intervention.
A positive screen should be followed immediately by:
- A visit to a pediatric neurologist or neuromuscular specialist
- Confirmatory genetic testing
- Discussion of treatment options — ideally within the first few weeks of life
Pediatricians may not always have updated information that treatment is available. But early enough identification, before symptoms appear, may mean the child never sees any muscular impact. (Source: Stanford Medicine Children’s Health Blog)
💊 FDA-Approved SMA Treatments in 2025–2026 — A Side-by-Side Comparison
The treatment landscape for SMA has transformed dramatically in just the past decade. There are now four FDA-approved disease-modifying therapies available. This is the table that most parents search for — and almost no one provides clearly.
| Treatment | Brand Name | Type | How Given | Who It’s For | Key Benefit |
|---|---|---|---|---|---|
| Nusinersen | Spinraza® (Biogen) | ASO therapy | Injection into spine every 4 months | All ages, all types | First ever disease-modifying therapy for SMA; approved for all ages |
| Risdiplam | Evrysdi® (Roche/Genentech) | Oral small molecule | Daily liquid taken by mouth or feeding tube | All types, ages 2 months+ | Can be given at home; no injections needed |
| Onasemnogene abeparvovec | Zolgensma® (Novartis) | Gene therapy | Single intravenous infusion | Children up to age 2 | One-time treatment; 91% of SMA Type 1 children treated with Zolgensma were alive at 14 months |
| Onasemnogene abeparvovec-brve | Itvisma® (Novartis) | Gene therapy | Injection into spine (intrathecal) | Ages 2 and older | FDA-approved for patients ages 2 and older; expands gene therapy access beyond toddlers |
Which Treatment Is Best?
This is the question every parent asks. And the honest answer is: it depends on your child’s age, SMA type, SMN2 copy number, and other individual factors. Your child’s neurologist is the right person to guide this decision.
That said, here is what the latest research shows:
After a two-year follow-up, children treated with Zolgensma required less breathing and nutritional support than those given Spinraza. Nearly twice as many children in the Spinraza group needed nighttime breathing support compared to the Zolgensma group. However, both therapies led to comparable improvements in motor function. (Source: JAMA Network Open via SMA News Today, Nov 2025)
A Note on Treatment Costs
This is something most websites avoid discussing — but parents deserve honesty.
| Treatment | Approximate Annual Cost | Notes |
|---|---|---|
| Spinraza (Evrysdi) | Up to $340,000 per year | Dosing is calibrated to weight, so may be less in younger patients |
| Zolgensma | ~$2.25 million (one-time) | Novartis offers payment plans, including outcome-based and over-time options up to 5 years |
| Evrysdi | Up to $340,000 per year | Oral; can be given at home, reducing ancillary costs |
Insurance coverage varies significantly. The Leukemia & Lymphoma Society and Cure SMA both offer financial navigation resources. Always ask your hospital’s social worker about patient assistance programs before assuming a treatment is unaffordable. (Source: Managed Healthcare Executive)
🌟 SMA and Children with Other Special Needs
Many of you are navigating SMA alongside another condition — and that layered reality deserves direct acknowledgment.
When SMA Co-Occurs with Other Conditions
A child can be diagnosed with SMA and also have:
- Down Syndrome — which brings its own motor development challenges that can mask or compound SMA symptoms
- Autism — where sensory sensitivities may make physical therapy, injections, and hospital visits significantly harder
- Intellectual disability — where communicating pain, fatigue, or difficulty with movement is limited
In these cases, each condition must be managed in coordination, not in isolation. A neurologist, pediatric physiatrist, and special education coordinator should ideally be part of the same care team conversation.
Practical Challenges Unique to These Families
| Challenge | Why It Matters | What to Do |
|---|---|---|
| Sensory aversions during treatment | Spinal injections (Spinraza) are especially difficult for children with sensory processing differences | Request child life specialist support; discuss sedation options with neurology |
| Feeding tube management with other conditions | Many children with SMA and co-occurring conditions require feeding tubes; coordination with GI specialists is essential | Ask for a multidisciplinary feeding team |
| Communication about symptoms | Non-verbal children cannot report increasing weakness or pain | Establish a symptom monitoring system with consistent observations and photographs |
| Physical therapy alignment | PT goals for SMA may conflict with PT goals for CP or Down Syndrome | Request a unified PT plan from a neuromuscular specialist |
| Parent cognitive load | Managing two complex diagnoses simultaneously is documented to increase caregiver burnout significantly | Access caregiver support programs through Cure SMA and your regional children’s hospital |
You are not doing anything wrong by finding this hard. You are finding it hard because it genuinely is. And reaching out for support is the most loving thing you can do — for yourself and for your child.
🏠 Daily Life with SMA — Practical Tips for Families
Here is what life with SMA actually involves — and how families make it manageable.
Mobility and Equipment
Children with SMA Type 2 and some Type 3 children use wheelchairs or powered mobility devices. Starting powered mobility early — even at age 2 — is now recommended by neuromuscular specialists, as it supports independence and cognitive development.
Useful equipment to discuss with your child’s care team:
- Power wheelchairs — available through Medicaid and many insurance plans
- Standers — help maintain bone density and joint health
- Cough assist devices — help clear secretions from the lungs in children with breathing difficulties
- Suction machines — for children with swallowing challenges
- AFOs (Ankle-Foot Orthoses) — support children with SMA Type 3 who are still walking
Home Adaptations
- Lower counters and switch positions where possible to support independence
- Install grab bars in bathrooms
- Use voice-activated smart home technology for light, temperature, and entertainment control
- Non-slip flooring and ramps at doorways
- Adjustable-height furniture
Nutrition and Feeding
Many children with SMA face feeding difficulties. In fact, for SMA Type 1 children, swallowing difficulties are common and can become a safety concern. Accordingly:
- Work with a speech-language pathologist who specializes in feeding
- Ask about the need for a feeding tube (gastrostomy) early, so the decision is planned rather than reactive
- Avoid foods that require significant chewing if swallowing is difficult
- Keep a feeding journal — track what works and what causes difficulty
🏫 SMA at School — IEP, 504, and Advocacy Checklist for Parents
This is one of the most searched-for topics by parents of children with SMA — and almost no awareness month post addresses it. Here is a practical, actionable guide.
Does Your Child Need an IEP or a 504 Plan?
| Plan Type | Best For | Key Benefit |
|---|---|---|
| IEP (Individualized Education Program) | Children with SMA whose condition affects academic performance or requires specialized instruction | Provides specialized services funded by the school |
| 504 Plan | Children with SMA whose condition requires accommodations but not specialized instruction | Faster to implement; good for physical access and fatigue accommodations |
Most children with SMA Type 1 or Type 2 will qualify for an IEP. Children with Type 3 who are ambulatory may do well with a 504 plan initially, transitioning to an IEP if their condition progresses.
Essential Accommodations to Request
Physical Access:
- [ ] Accessible classroom on the ground floor or near an elevator
- [ ] Accessible restroom with privacy support as needed
- [ ] Reserved accessible parking space for drop-off
- [ ] Permission to leave class early to avoid crowded hallways
- [ ] Adjustable-height desk and seating that supports posture
Academic and Fatigue Accommodations:
- [ ] Extended time on all tests and assignments
- [ ] Reduced writing demands — use of speech-to-text software or scribe
- [ ] Shortened school day option if fatigue is significant
- [ ] Rest breaks built into the daily schedule
- [ ] Permission to record classes or receive class notes
Emergency and Health Protocols:
- [ ] Individual health plan (IHP) on file with the school nurse
- [ ] Emergency action plan for breathing difficulty or sudden decline
- [ ] Clear protocol for what to do if the child’s power wheelchair fails
- [ ] Staff training on the child’s specific SMA type and needs
Technology Support:
- [ ] AAC (Augmentative and Alternative Communication) device if the child has speech difficulties
- [ ] Computer or tablet access for all written work
- [ ] Eye-gaze technology for children with very limited hand function
A parent tip: Bring a letter from your child’s neurologist or neuromuscular specialist to every IEP meeting. Having medical documentation that directly addresses school limitations carries significantly more weight than parent reporting alone. (Source: Cure SMA Community Resources)
💛 Emotional Support for SMA Families — You Are Not Navigating This Alone
Receiving an SMA diagnosis — whether at birth through newborn screening or after months of watching your child struggle to meet milestones — is a shock that reshapes everything. It reshapes your identity as a parent. It reshapes your relationship with your partner. It reshapes your relationship with hope itself.
And if your child already has another special need, you may be carrying two different kinds of grief simultaneously. Both are valid. Both deserve space.
What Families Often Experience
- Relief at finally having a name for what they have been watching — followed immediately by fear of what comes next
- Guilt — wondering if they should have pushed earlier, researched sooner, insisted louder
- Anticipatory grief — grieving milestones that may not come, while trying to celebrate the ones that do
- Isolation — because very few people in your life will understand what SMA really means in daily terms
- And also — hope. Because in 2025 and 2026, SMA treatment is genuinely transforming outcomes in ways that were unimaginable a decade ago
Practical Support Resources
- 🌐 Cure SMA — the leading SMA organization; offers family conferences, community connections, and a helpline
- 🌐 MDA (Muscular Dystrophy Association) — offers camps, clinics, and family support programs for neuromuscular conditions including SMA
A Message for SMA Awareness Month
SMA Awareness Month strives to shine a brighter spotlight on the needs, wants, hopes, and experiences of the community. (Source: Cure SMA)
That includes you. The parent who researched until 2am. The caregiver who learned to use a cough assist machine at home. The sibling who learned to wait more, love more, and ask fewer questions than other kids their age.
This month is for all of you. And so is HopeForSpecial. 💚
Importance of SMA Awareness Month
Let us dig into why Spinal Muscular Atrophy Awareness Month is crucial.
Support Research Efforts
This special month raises funds for research into cures and treatments for spinal muscular atrophy. It helps in boosting the quality of life for those affected with SMA.
Inspire Hope
SMA awareness month increases inspiration and hope for people with SMA along with their families. It motivates them to fight challenges in their life and live a satisfactory life.
Increases Public Awareness
SMA month breaks down the misconceptions linked with this genetic condition.
Supports SMA Community
This month gives an opportunity to connect with the SMA community and offer support to people and their families affected by SMA.
Promotes Early Diagnosis of SMA
Spinal Muscular Atrophy Awareness Month motivates patients to get medical treatment on time. As you know, early diagnosis results in prompt intervention and good results.
How to Participate in Spinal Muscular Atrophy Awareness Month?
Checkout the activities for SMA month:
Connect with the SMA Community
- Take part in an SMA event near you.
Show Your Support for Spinal Muscular Atrophy
- Don green-colored clothes or accessories.
Educate Yourself About SMA
- know the ins and outs of spinal muscular atrophy online.
Support Policies and Research Funds
- Join advocacy groups.
- Get in touch with the skilled representatives that support research funds to help people with spinal muscular atrophy.
Voice Search
What is the color for Spinal Muscular Atrophy Awareness Month?
The official SMA month color is green. This color signifies growth, new life, and hope.
What is the Symbol of SMA Month?
The spinal muscular atrophy month symbol is a butterfly. Their vibrant shades and soft wings show beauty and strength to those living with SMA. Butterflies also symbolize hope, resilience, and transformation.
❓ FAQs — Spinal Muscular Atrophy Awareness Month
Q: What month is Spinal Muscular Atrophy Awareness Month?
Spinal Muscular Atrophy Awareness Month is observed every August. It was founded in 1996 by Cure SMA and has been recognized nationally and internationally ever since. August is the time to shine a brighter spotlight on the needs, wants, hopes, and experiences of the SMA community. (Source: Cure SMA)
Q: What is the most common type of SMA in children?
SMA Type 1 is the most common and most severe form, accounting for roughly 60% of all diagnoses. It appears in the first six months of life. Without treatment, most children with Type 1 will not survive beyond 2 years of age without permanent ventilatory support. With early treatment, however, outcomes have transformed dramatically. (Source: Clinical Trials / Oxford)
Q: Can a child with SMA go to school?
Yes — absolutely. Most children with SMA can attend school with appropriate accommodations. An IEP or 504 Plan can provide accessible seating, extended time, technology support, and a health emergency plan. Children with SMA Type 3 may attend with relatively minor physical accommodations. Children with Types 1 and 2 may require more comprehensive support but are fully entitled to education.
Q: Is SMA hereditary?
Yes. SMA is an autosomal recessive condition. Both parents must each pass down a non-working SMN1 gene for a baby to have SMA. If two parents are carriers, they have a 1 in 4 chance of having a child with SMA. Carriers do not have or develop the condition themselves. (Source: HRSA Newborn Screening)
Q: What is the newest SMA treatment approved by the FDA?
As of 2025–2026, there are four FDA-approved disease-modifying therapies for SMA: Spinraza, Evrysdi, Zolgensma (for children under 2), and Itvisma (for patients 2 and older). Itvisma is a one-time gene therapy FDA-approved for patients ages 2 and older — making gene therapy available to a broader age range than ever before. (Source: SMA News Today)
Q: How early can SMA be detected?
SMA can be detected through newborn screening — ideally within the first days of life. All patients identified through newborn screening were seen promptly, with diagnosis confirmed within 1 week of the initial clinical visit. The earlier treatment begins, the better the outcomes. (Source: NIH / PMC)
Q: What is the green ribbon for SMA Awareness Month?
The green ribbon is the official symbol of Spinal Muscular Atrophy awareness. Wearing or displaying a green ribbon during August shows solidarity with SMA families and helps raise awareness. The butterfly is another beloved SMA symbol, representing hope, resilience, and transformation.
Conclusion
Spinal Muscular Atrophy Awareness Month is a perfect time to get together as a community. It even increase awareness, inspire hope, and show support to those affected by SMA. Together, we can create a significant difference in the lives of patients and create a future where this genetic disorder is no longer a burden.


